Examining the Potential Price Growth of Rocket Lab Corp (RKLB)

Rocket Lab Corp’s recently made public that its Director Saintil Merline unloaded Company’s shares for reported $0.19 million on Jun 20 ’25. In the deal valued at $29.41 per share,6,353 shares were sold. As a result of this transaction, Saintil Merline now holds 425,922 shares worth roughly $13.96 million.

Then, MERLINE SAINTIL bought 12,706 shares, generating $353,862 in total proceeds.

Before that, Ocko Matthew sold 820,000 shares. Rocket Lab Corp shares valued at $21,325,494 were divested by the Director at a price of $26.01 per share. As a result of the transaction, Ocko Matthew now holds 1,083,053 shares, worth roughly $35.5 million.

Needham initiated its Rocket Lab Corp [RKLB] rating to a Buy in a research note published on April 25, 2025; the price target was $28. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in mid September with a ‘”a Mkt perform”‘ rating. Morgan Stanley also remained covering RKLB and has decreased its forecast on July 15, 2024 with a “an Equal-weight” recommendation from previously “an Overweight” rating. BTIG Research started covering the stock on June 26, 2024. It rated RKLB as “a Neutral”.

Price Performance Review of RKLB

On Monday, Rocket Lab Corp [NASDAQ:RKLB] saw its stock jump 9.12%% to $32.78. Over the last five days, the stock has gained 29.00%. Rocket Lab Corp shares have risen nearly 567.62% since the year began. Nevertheless, the stocks have risen 28.70% over the past one year. While a 52-week high of $33.34 was reached on 01/24/25, a 52-week low of $4.20 was recorded on 04/07/25.

Levels Of Support And Resistance For RKLB Stock

The 24-hour chart illustrates a support level at 29.84, which if violated will result in even more drops to 26.89. On the upside, there is a resistance level at 34.33. A further resistance level may holdings at 35.87.

The most recent change occurred on June 11, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $4.50 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.